Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related LJPC
The Most Notable Insider Buys And Sells Of Last Week
La Jolla Pharma Could Nearly Triple, Cowen Says
Related DRII
Benzinga's Top Downgrades
Watch These 7 Huge Call Purchases In Friday Trade

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

DateFirmActionFromTo
Jun 2016SunTrust Robinson HumphreyInitiates Coverage onBuy
Feb 2016Cowen & CompanyInitiates Coverage onOutperform
Apr 2015OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (LJPC + DRII)

View Comments and Join the Discussion!